Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension

Hypertension

Volumn 62, Issue 3, 2013, Pages 564-571

  Huang, Bing S ^a   White, Roselyn A ^a   Ahmad, Monir ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

aldosterone synthase; cerebrospinal fluid; eplerenone; infusions, central or intracerebroventricular

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN II; CORTICOSTERONE; MINERALOCORTICOID RECEPTOR;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRAIN LEVEL; CEREBROSPINAL FLUID; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FLUID INTAKE; HYPERTENSION; HYPOTHALAMUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT;

ALDOSTERONE SYNTHASE; CEREBROSPINAL FLUID; EPLERENONE; INFUSIONS, CENTRAL OR INTRACEREBROVENTRICULAR;

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BRAIN; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FADROZOLE; HEART RATE; HYPERTENSION; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE;

EID: 84883309048     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01557     Document Type: Article

References (34)

1. Fink GD. Long-term sympatho-excitatory effect of angiotensin II: A mechanism of spontaneous and renovascular hypertension. Clin Exp Pharmacol Physiol. 1997;24:91-95.
2. Li Q, Dale WE, Hasser EM, Blaine EH. Acute and chronic angiotensin hypertension: Neural and nonneural components, time course, and dose dependency. Am J Physiol. 1996;271(1 Pt 2):R200-R207.
3. Davern PJ, Head GA. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension. 2007;49:1170-1177.
4. Huang BS, Ahmadi S, Ahmad M, White RA, Leenen FHH. Central neuronal activation and pressor responses induced by circulating angiotensin II: Role of brain aldosterone-"ouabain" pathway. Am J Physiol. 2010; 299: H422-H430.
5. Xue B, Beltz TG, Yu Y, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Central interactions of aldosterone and angiotensin II in aldosterone-and angiotensin II-induced hypertension. Am J Physiol. 2010; 300: H555-H564.
6. Yoshika M, Komiyama Y, Takahashi H. An ouabain-like factor is secreted from immortalized hypothalamic cells in an aldosterone-dependent manner. Neurochem Int. 2011;59:104-108.
7. Huang BS, Zheng H, Tan J, Patel KP, Leenen FH. Regulation of hypothalamic renin-angiotensin system and oxidative stress by aldosterone. Exp Physiol. 2011;96:1028-1038.
8. Li YF, Wang W, Mayhan WG, Patel KP. Angiotensin-mediated increase in renal sympathetic nerve discharge within the PVN: Role of nitric oxide. Am J Physiol. 2006; 290: R1035-R1043.
9. Hogarty DC, Speakman EA, Puig V, Phillips MI. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Brain Res. 1992;586:289-294.
10. Hamlyn JM, Leenen FHH, Golovina VA, Linde CI, Gao J, Huang BS, Ahmad M, Chen L, Li M, Blaustein MP. Central angiotensin II increases circulating endogenous ouabain, arterial myocytes Na/Ca exchanger expression and blood pressure via brain aldosterone and mineralocorticoid receptors. High Blood Pressure Research 2012 Scientific Sessions. September 19-22, 2012. Abstract #419.
11. Xue B, Zhang Z, Johnson RF, Johnson AK. Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: Induction of sensitization by prior Ang II treatment. Hypertension. 2012;59:459-466.
12. Yu Y, Wei SG, Zhang ZH, Gomez-Sanchez E, Weiss RM, Felder RB. Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failuré Hypertension. 2008;51:727-733.
13. Geerling JC, Loewy AD. Aldosterone in the brain. Am J Physiol. 2009; 297:F559-F576.
14. Campese VM, Ye S, Zhong H. Downregulation of neuronal nitric oxide synthase and interleukin-1beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension. 2002;39(2 Pt 2):519-524.
15. Ufnal M, Sikora M, Zera T, Szczepanska-Sadowska E. Simvastatin reduces pressor response to centrally administered angiotensin II. Am J Hypertens. 2010;23:956-959.
16. Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H] dopa in various regions of the brain. J Neurochem. 1966;13:655-669.
17. Huang BS, White RA, Ahmad M, Jeng AY, Leenen FHH. Central infusion of aldosterone synthase inhibitor prevents sympathetic hyperactivity and hypertension by central Na+ in Wistar rats. Am J Physiol. 2008;295:R166-R172.
18. Huang BS, Leenen FH. Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain ANG II. Am J Physiol. 1996;270(1 Pt 2):H275-H280.
19. McKinley MJ, Badoer E, Vivas L, Oldfield BJ. Comparison of c-fos expression in the lamina terminalis of conscious rats after intravenous or intracerebroventricular angiotensin. Brain Res Bull. 1995;37:131-137.
20. Veerasingham SJ, Leenen FH. Excitotoxic lesions of the ventral anteroventral third ventricle and pressor responses to central sodium, ouabain and angiotensin II. Brain Res. 1997;749:157-160.
21. Nakagaki T, Hirooka Y, Matsukawa R, Nishihara M, Nakano M, Ito K, Hoka S, Sunagawa K. Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats. Hypertens Res. 2012;35:470-476.
22. Amin MS, Wang HW, Reza E, Whitman SC, Tuana BS, Leenen FHH. Distribution of epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory centers in rat brain. Am J Physiol. 2005; 289:R1787-R1797.
23. Kumar NN, Goodchild AK, Li Q, Pilowsky PM. An aldosterone-related system in the ventrolateral medulla oblongata of spontaneously hypertensive and Wistar-Kyoto rats. Clin Exp Pharmacol Physiol. 2006;33:71-75.
24. Oshima N, Onimaru H, Takechi H, Yamamoto K, Watanabe A, Uchida T, Nishida Y, Oda T, Kumagai H. Aldosterone is synthesized in and activates bulbospinal neurons through mineralocorticoid receptors and ENaCs in the RVLM. Hypertens Res. 2013;36:504-512.
25. Schelling P, Ganten U, Sponer G, Unger T, Ganten D. Components of the renin-angiotensin system in the cerebrospinal fluid of rats and dogs with special consideration of the origin and the fate of angiotensin II. Neuroendocrinology. 1980;31:297-308.
26. Mikami H, Suzuki H, Smeby RR, Ferrario CM. Cerebrospinal fluid angiotensin II immunoreactivity is not derived from the plasma. Hypertension. 1985;7:65-71.
27. Collister JP, Hendel MD. Chronic effects of angiotensin II and AT1 receptor antagonists in subfornical organ-lesioned rats. Clin Exp Pharmacol Physiol. 2005;32:462-466.
28. Wang W, Ma R. Cardiac sympathetic afferent reflexes in heart failure. Heart Fail Rev. 2000;5:57-71.
29. Pan YX, Gao L, Wang WZ, Zheng H, Liu D, Patel KP, Zucker IH, Wang W. Exercise training prevents arterial baroreflex dysfunction in rats treated with central angiotensin II. Hypertension. 2007;49:519-527.
30. Peterson JR, Burmeister MA, Tian X, Zhou Y, Guruju MR, Stupinski JA, Sharma RV, Davisson RL. Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II. Hypertension. 2009;54:1106-1114.
31. Yamada K, Goto A, Omata M. Modulation of the levels of ouabainlike compound by central catecholamine neurons in rats. FEBS Lett. 1995;360:67-69.
32. Yamada K, Goto A, Hui C, Omata M. Role of ouabain-like compound in the regulation of plasma aldosterone concentration in rats. Life Sci. 1996;58:1833-1837.
33. Rigel DF, Fu F, Beil M, Hu CW, Liang G, Jeng AY. Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: Comparison with the 11beta-hydroxylase inhibitor metyrapone. J Pharmacol Exp Ther. 2010;334:232-243.
34. Zhang ZH, Kang YM, Yu Y, Wei SG, Schmidt TJ, Johnson AK, Felder RB. 11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation. Hypertension. 2006;48:127-133.